1. Home
  2. SENEA vs EVO Comparison

SENEA vs EVO Comparison

Compare SENEA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seneca Foods Corp.

SENEA

Seneca Foods Corp.

HOLD

Current Price

$134.86

Market Cap

908.7M

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.16

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SENEA
EVO
Founded
1949
1993
Country
United States
Germany
Employees
6895
4553
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
908.7M
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SENEA
EVO
Price
$134.86
$3.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
112.3K
107.4K
Earning Date
06-11-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
$13.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$84.66
$2.31
52 Week High
$167.52
$4.80

Technical Indicators

Market Signals
Indicator
SENEA
EVO
Relative Strength Index (RSI) 37.54 60.08
Support Level $129.17 $2.87
Resistance Level $148.97 $3.78
Average True Range (ATR) 8.30 0.11
MACD -3.55 0.06
Stochastic Oscillator 22.89 71.91

Price Performance

Historical Comparison
SENEA
EVO

About SENEA Seneca Foods Corp.

Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: